Sequana Medical NV
XBRU:SEQUA
Sequana Medical NV
XBRU:SEQUA
Price:
0.516
EUR
-2.64%
Market Cap:
€38.5m
Cash Flow Statement
Cash Flow Statement
Sequana Medical NV
Sequana Medical NV
Currency: EUR
| Sep-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(10)
|
(14)
|
(16)
|
(15)
|
(17)
|
(19)
|
(21)
|
(24)
|
(27)
|
(31)
|
(32)
|
(33)
|
(27)
|
(45)
|
(52)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
1
|
4
|
5
|
26
|
35
|
|
| Cash Taxes Paid |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash Interest Paid |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Change in Working Capital |
1
|
3
|
(3)
|
(5)
|
(0)
|
1
|
0
|
(2)
|
(1)
|
1
|
1
|
(1)
|
(3)
|
(2)
|
(1)
|
|
| Cash from Operating Activities |
(8)
N/A
|
(10)
-24%
|
(18)
-82%
|
(18)
-3%
|
(16)
+16%
|
(17)
-9%
|
(20)
-15%
|
(24)
-20%
|
(25)
-8%
|
(27)
-8%
|
(30)
-9%
|
(29)
+3%
|
(25)
+13%
|
(20)
+20%
|
(18)
+13%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-287%
|
(0)
-252%
|
(0)
-74%
|
(0)
+33%
|
(0)
+37%
|
(0)
-30%
|
(0)
-83%
|
(1)
-110%
|
(1)
+8%
|
(0)
+55%
|
(1)
-147%
|
(1)
+7%
|
(0)
+85%
|
(0)
+29%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
26
|
26
|
19
|
19
|
23
|
23
|
28
|
28
|
16
|
16
|
12
|
12
|
3
|
|
| Net Issuance of Debt |
6
|
10
|
4
|
(2)
|
(0)
|
4
|
4
|
(0)
|
(0)
|
9
|
9
|
(1)
|
2
|
10
|
18
|
|
| Other |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
5
N/A
|
9
+75%
|
30
+213%
|
23
-22%
|
18
-22%
|
23
+26%
|
27
+17%
|
22
-16%
|
28
+25%
|
37
+33%
|
24
-35%
|
13
-44%
|
12
-11%
|
22
+80%
|
21
-3%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(3)
N/A
|
(0)
+86%
|
12
N/A
|
4
-63%
|
2
-53%
|
5
+171%
|
7
+27%
|
(1)
N/A
|
2
N/A
|
9
+357%
|
(6)
N/A
|
(16)
-170%
|
(14)
+14%
|
1
N/A
|
3
+158%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(8)
N/A
|
(10)
-25%
|
(18)
-83%
|
(19)
-4%
|
(16)
+16%
|
(17)
-9%
|
(20)
-15%
|
(24)
-21%
|
(26)
-9%
|
(28)
-8%
|
(30)
-7%
|
(30)
+1%
|
(26)
+13%
|
(20)
+22%
|
(18)
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
